TOP TIERMARKET NEWSWIRE

News & sentiment

BRIGHT MINDS BIOSCIE (DRUG) — News & AI sentiment

BRIGHT MINDS BIOSCIE (DRUG) news roundup. 22 stories in the past week, 23 over 30 days. Average 30-day sentiment is 33.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

22

avg sentiment 32.5/100

30d stories

23

avg sentiment 33.9/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

DRUG news in the last 24 hours, 7 days, 30 days and 90 days

How much DRUG coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	DRUG stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	22	32.5/100	DRUG headlines →
Last 30 days	23	33.9/100	DRUG headlines →
Last 90 days	35	42.5/100	DRUG headlines →

Latest stories on DRUG

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Bright Minds Biosciences (DRUG)

GlobeNewswire34 · bearishgeneral

4d ago

Bright Minds Biosciences: Promising Catalysts Despite The FDA Setback

Seeking Alpha48 · neutralgeneral

4d ago

BRIGHT MINDS BIOSCIENCES INVESTIGATION: DRUG Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

GlobeNewswire34 · bearishgeneral

4d ago

Bright Minds Biosciences: Downgrade To 'Hold' On BMB-101 Setback DEE And Progression Into PWS

Seeking Alpha34 · bearishanalyst

5d ago

DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences

PR Newswire34 · bearishgeneral

5d ago

Bright Minds Price Target Lowered To 107 From 126 At Baird

The Fly34 · bearishanalyst

6d ago

Bright Minds Biosciences Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Bright Minds Biosciences (DRUG)

PR Newswire34 · bearishgeneral

6d ago

Bright Minds price target lowered to $37 from $147 at BTIG

The Fly22 · bearishanalyst

6d ago

Bright Minds shares fall as BTIG cuts price target on clinical hold

Investing.com Analyst Ratings34 · bearishanalyst

6d ago

Sector Update: Healthcare

Fidelity News34 · bearishgeneral

6d ago

Top Midday Decliners

Fidelity News14 · bearishproduct/pr

6d ago

Why Did Bright Minds Biosciences Stock Drug Plummet 55 Today

The Fly12 · bearishgeneral

7d ago

Jefferies cuts Bright Minds stock price target on trial delays

Investing.com Analyst Ratings34 · bearishanalyst

7d ago

Baird cuts Bright Minds stock price target on clinical hold delay

Investing.com Analyst Ratings34 · bearishanalyst

7d ago

FDA Imposes Partial Clinical Hold on Bright Minds Biosciences (DRUG) Phase 2 Trial

GuruFocus34 · bearishgeneral

7d ago

Bright Minds Biosciences Faces Partial FDA Clinical Hold on BMB-101 Phase 2 Epilepsy Study

InvestorsHub34 · bearishgeneral

7d ago

Bright Minds BMB-101 partial hold clouds U.S. DEE timeline, says H.C. Wainwright

The Fly34 · bearishanalyst

7d ago

Why is Bright Minds Biosciences stock collapsing today?

Investing.com Markets22 · bearishgeneral

7d ago

Bright Minds stock plunges as FDA halts epilepsy trial

Investing.com Markets22 · bearishgeneral

7d ago

FDA places clinical hold on Bright Minds BMB-101-105 IND application

The Fly22 · bearishgeneral

7d ago

Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies

Business Insider56 · neutralproduct/pr

7d ago

Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies

GlobeNewswire56 · neutralproduct/pr

7d ago

Bright Minds initiated with an Outperform at Wolfe Research

The Fly63 · neutralanalyst

Oct 15

Teradyne Invests in Bright Machines as AI Infrastructure Manufacturing Shifts Toward Software-Defined Factories October 5, 2026

MarketChameleon67 · bullishproduct/pr

Oct 5

Teradyne Makes Strategic Investment in Bright Machines to Advance AI Infrastructure Manufacturing

Business Insider63 · neutralproduct/pr

Oct 5

Open DRUG in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →